Researchers at The Wistar Institute's HIV Cure and Viral Diseases Center have successfully identified a new approach using ...
The NK cell therapy market is experiencing significant growth, driven by rising interest in immuno-oncology and advancements in cell engineering technologies. Increasing clinical trials, strategic ...
The American people have consistently supported life-saving cancer research. Now the nation’s bedrock source of public ...
An investigational therapy significantly shrank lung cancer tumors that are notoriously resistant to treatment by encouraging ...
The following is a summary of “First-in-human evaluation of memory-like NK cells with an IL-15 super-agonist and CTLA-4 ...
To assess whether NK cells were involved in antitumor response generated by fasting, Delconte and her team depleted these ...
and efficacy of CAR-T and CAR-Natural Killer (NK) cells. Its key features include: Bispecific Anti-CD19xCD22 CAR: This design targets both CD19 and CD22 antigens, minimizing the risk of tumor escape ...
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today presented data at the American Association for Cancer Research (AACR) IO Annual Meeting ...